Gene: EPHB6
Official Full Name: EPH receptor B6provided by HGNC
Gene Summary: This gene encodes a member of a family of transmembrane proteins that function as receptors for ephrin-B family proteins. Unlike other members of this family, the encoded protein does not contain a functional kinase domain. Activity of this protein can influence cell adhesion and migration. Expression of this gene is downregulated during tumor progression, suggesting that the protein may suppress tumor invasion and metastasis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO37989 | EPHB6 Knockout cell line (HCT 116) | Human | EPHB6 | 1:2~1:4 | Negative | Online Inquiry |
EPHB6 Gene Knockout Cell Lines are specifically designed cellular models that have undergone genetic modification to disable the EPHB6 gene. EPHB6 encodes a receptor tyrosine kinase involved in various cellular processes, including cell adhesion, migration, and proliferation, playing a critical role in developmental biology and neurobiology. By knocking out the EPHB6 gene, these cell lines serve as a valuable research tool for elucidating the gene's function in biological systems, particularly in contexts such as cancer metastasis, neurodevelopmental disorders, and cellular signaling pathways.
The primary mechanism of these knockout cell lines involves the use of CRISPR-Cas9 technology, which allows for precise gene editing by creating double-strand breaks at specific genomic locations. This targeted editing results in frameshifts or deletions in the EPHB6 gene, leading to a complete loss of function. Consequently, researchers can observe the downstream effects of EPHB6 absence on cellular behavior, providing insights into its biological roles and potential therapeutic targets.
The scientific importance of EPHB6 Gene Knockout Cell Lines extends across diverse research and clinical applications. These models facilitate the exploration of EPHB6-mediated signaling pathways, contributing to our understanding of complex diseases and aiding in the development of effective intervention strategies. Furthermore, they enable the screening of potential drugs targeting EPHB6-related pathways, thus holding promise for the discovery of novel therapeutic agents.
Compared to alternative models, EPHB6 Gene Knockout Cell Lines offer more specificity and reduced variability, as conventional approaches, like RNA interference, may lead to incomplete or transient gene suppression. This results in clearer experimental outcomes and more reliable data, which are essential for both basic and translational research.
For researchers and clinicians seeking to advance their understanding of cellular mechanisms, EPHB6 Gene Knockout Cell Lines represent a critical asset. Their ability to provide definitive insights into the role of EPHB6 positions them as a powerful tool in elucidating the complexities of cell behavior and disease progression.
At our company, we pride ourselves on being at the forefront of innovative genetic tools, offering high-quality biological products like EPHB6 Gene Knockout Cell Lines that empower researchers to unlock new avenues in understanding and treating diseases.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.